These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23992305)

  • 1. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol.
    Hsieh TC; Bennett DJ; Lee YS; Wu E; Wu JM
    Curr Med Chem; 2013; 20(33):4195-202. PubMed ID: 23992305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
    Hsieh TC
    Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
    Hsieh TC; Yang CJ; Lin CY; Lee YS; Wu JM
    Carcinogenesis; 2012 Mar; 33(3):670-7. PubMed ID: 22266466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.
    Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM
    PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells.
    Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).
    Nolan KA; Caraher MC; Humphries MP; Bettley HA; Bryce RA; Stratford IJ
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7331-6. PubMed ID: 21074425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.
    Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C
    Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.
    Potter GA; Patterson LH; Wanogho E; Perry PJ; Butler PC; Ijaz T; Ruparelia KC; Lamb JH; Farmer PB; Stanley LA; Burke MD
    Br J Cancer; 2002 Mar; 86(5):774-8. PubMed ID: 11875742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53.
    Hsieh TC; Wang Z; Hamby CV; Wu JM
    Biochem Biophys Res Commun; 2005 Aug; 334(1):223-30. PubMed ID: 15993843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit.
    Alarma-Estrany P; Crooke A; Pintor J
    J Pineal Res; 2009 Sep; 47(2):201-209. PubMed ID: 19627460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.
    Megarity CF; Gill JR; Caraher MC; Stratford IJ; Nolan KA; Timson DJ
    FEBS Lett; 2014 May; 588(9):1666-72. PubMed ID: 24631540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis.
    Dorai T; Shah A; Summers F; Mathew R; Huang J; Hsieh TC; Wu JM
    Prostate; 2018 Nov; 78(15):1181-1195. PubMed ID: 30009389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism-based inhibition of quinone reductase 2 (NQO2): selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition.
    Dufour M; Yan C; Siegel D; Colucci MA; Jenner M; Oldham NJ; Gomez J; Reigan P; Li Y; De Matteis CI; Ross D; Moody CJ
    Chembiochem; 2011 May; 12(8):1203-8. PubMed ID: 21506232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico screening reveals structurally diverse, nanomolar inhibitors of NQO2 that are functionally active in cells and can modulate NF-κB signaling.
    Nolan KA; Dunstan MS; Caraher MC; Scott KA; Leys D; Stratford IJ
    Mol Cancer Ther; 2012 Jan; 11(1):194-203. PubMed ID: 22090421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three Australian Lepidosperma Labill. Species as sources of prenylated and oxyprenylated derivatives of piceatannol, resveratrol and pinosylvin: Melatoninergic binding and inhibition of quinone reductase 2.
    Hamid K; Tran VH; Duke RK; Duke CC
    Phytochemistry; 2022 Nov; 203():113396. PubMed ID: 35998831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
    Leung KK; Shilton BH
    Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.
    Kucera HR; Livingstone M; Moscoso CG; Gaikwad NW
    Free Radic Res; 2013 Dec; 47(12):1016-26. PubMed ID: 24074361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
    Ahn KS; Gong X; Sethi G; Chaturvedi MM; Jaiswal AK; Aggarwal BB
    Cancer Res; 2007 Oct; 67(20):10004-11. PubMed ID: 17942934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of piceatannol: leaving the shadow of resveratrol.
    Piotrowska H; Kucinska M; Murias M
    Mutat Res; 2012; 750(1):60-82. PubMed ID: 22108298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.